Assessing the safety of low-dose primaquine in plasmodium falciparum-infected African children with glucose 6 phosphate dehydrogenase deficiency

This website will not work correctly in Internet Explorer 11 and it is strongly recommended that you upgrade to an up-to-date browser. Internet Explorer 11 will go out of support and be retired on June 15, 2022. For more information on upgrading please see browser-update.org.

Joint Global Health Trials scheme

Year of award: 2016

Prof Nicholas Day
University of Oxford

Grantholders

Prof Nicholas Day